Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

A practical review of the neuropathology and neuroimaging of multiple sclerosis.
Novel Immune Regulator Shows Promise as MS Therapy in Clinical Trials
Identification of Selective Inhibitors of the Potassium Channel Kv1.1-1.2((3)) by High-Throughput Virtual Screening and Automated Patch Clamp.
Meralgia paresthetica after subcutaneous injection of glatiramer acetate.
Effectiveness of Natalizumab in Patients with Highly Active Relapsing Remitting Multiple Sclerosis.
Switching from natalizumab to fingolimod: A randomized, placebo-controlled study in RRMS.
Impact of glatiramer acetate on paraclinical markers of neuroprotection in multiple sclerosis: A prospective observational clinical trial.
LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex.
Artielle Immunotherapeutics Announces Positive Results of Phase ! Multiple Sclerosis Trial
The delta-subunit of the epithelial sodium channel (ENaC) enhances channel activity and alters proteolytic ENaC activation.
Efficacy and safety of interferon beta-1b sc in older RRMS patients--a posthoc analysis of the BEYOND study.
Severe anemia in a patient with multiple sclerosis treated with natalizumab.
The neutralizing antibody GNbAC1 abrogates HERV-W envelope protein-mediated oligodendroglial maturation blockade.
Multiple sclerosis.
The OSCAR-IB Consensus Criteria for Retinal OCT Quality Assessment.
Galectin-1 for neuroprotection?
Calcitriol Modulates the CD46 Pathway in T Cells.
Predicted structure of MIF/CD74 and RTL1000/CD74 complexes.
Liposarcoma concurrence in a multiple sclerosis patient treated with interferon-beta 1b.
Effect of met-enkephalin on chromosomal aberrations in the lymphocytes of the peripheral blood of patients with multiple sclerosis.
Pharmacokinetic profile of dalfampridine extended release: clinical relevance in patients with MS.
Effect of Genzyme’s LEMTRADA™ maintained in patients beyond two-year pivotal MS studies
Mycoplasma pneumonia seroposivity in Iranian patients with relapsing-remitting multipl sclerosis: a randomized case-control study.
Modulation of nitric oxide synthase by arginase and methylated arginines during the acute phase of experimental multiple sclerosis.
Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome.

Pages